Trends in development cycles. Market indicators

Nature Reviews Drug Discovery

Volumn 1, Issue 5, 2002, Pages 335-336

  Bolten, Barbara M ^a   DeGregorio, Tracy ^a  

^a Decision Resources Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG DESIGN; DRUG INDUSTRY; CHEMICAL GENETICS; COMBINATORIAL LIBRARY; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG RESEARCH; DRUG TARGETING; NOTE; PHARMACOGENOMICS; PRIORITY JOURNAL;

DRUG DESIGN; DRUG INDUSTRY;

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; NEW DRUG; RESPIRATORY TRACT AGENT;

EID: 0036562364     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd805     Document Type: Note

References (1)

1. Kaitin, K. I. #38; DiMasi, J. A. Measuring the pace of new drug development in the user fee era. Drug Inf. J. 34, 673-680 (2000).